The burden of adverse drug reactions reported by patients in the Dutch ADR monitor: a proof of concept.
Janneke M QuikHelen R GosseltJette A van LintLeanne J KossePeter M Ten KloosterHarald E VonkemanBartholomeus J F van den BemtNaomi T JessurunPublished in: Expert opinion on drug safety (2024)
This is the first study investigating burden of ADRs on 7 domains in patients with chronic diseases. Impact on the domain fatigue was considered most burdensome.